Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Equillium Inc (NQ: EQ ) 0.7851 -0.0248 (-3.06%) Streaming Delayed Price Updated: 3:58 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Equillium Inc < Previous 1 2 3 Next > Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights August 08, 2024 From Equillium Inc. Via Business Wire Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease August 06, 2024 From Equillium, Inc. Via Business Wire Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance July 18, 2024 From Equillium, Inc. Via Business Wire Equillium to Participate in Upcoming Investor Conferences July 02, 2024 From Equillium, Inc. Via Business Wire Equillium to be included in the Russell Microcap® Index June 12, 2024 From Equillium, Inc. Via Business Wire Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 05, 2024 From Equillium, Inc. Via Business Wire Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata June 04, 2024 From Equillium Inc. Via Business Wire Equillium to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Equillium, Inc. Via Business Wire Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease May 14, 2024 From Equillium, Inc. Via Business Wire Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights May 09, 2024 From Equillium Inc. Via Business Wire Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists May 07, 2024 From Equillium, Inc. Via Business Wire Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 03, 2024 From Equillium, Inc. Via Business Wire Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis April 01, 2024 From Equillium, Inc. Via Business Wire Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights March 25, 2024 From Equillium, Inc. Via Business Wire Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference March 22, 2024 From Equillium, Inc. Via Business Wire Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease December 21, 2023 From Equillium, Inc. Via Business Wire Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology November 13, 2023 From Equillium, Inc. Via Business Wire Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates November 08, 2023 From Equillium, Inc. Via Business Wire Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology November 06, 2023 From Equillium, Inc. Via Business Wire 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis October 23, 2023 Via ACCESSWIRE Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology October 19, 2023 From Equillium Via Business Wire Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium October 16, 2023 From Equillium Inc. Via Business Wire Equillium to Host Analyst & Investor Day October 03, 2023 From Equillium, Inc. Via Business Wire Equillium to Present at the JonesTrading 2023 Healthcare Summit October 02, 2023 From Equillium, Inc. Via Business Wire Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences September 20, 2023 From Equillium, Inc. Via Business Wire Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference August 30, 2023 From Equillium, Inc. Via Business Wire Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates August 09, 2023 From Equillium, Inc. Via Business Wire Equillium Announces $7.5 Million Share Repurchase Program August 02, 2023 From Equillium, Inc. Via Business Wire Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences June 01, 2023 From Equillium, Inc. Via Business Wire Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists May 15, 2023 From Equillium, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.